Friday, September 17, 2021 12:49:35 PM
Due to increased pressure from, among others, tobacco control and public health groups, members of Congress, academic institutions, family advocacy organizations and attorneys general, we believe that the FDA has used the September 9, 2021 PMTA deadline to effectively “ban” flavored ENDS by denying nearly all pending PMTAs for such products. As of September 10, 2021, the FDA announced that it has taken action on over 93% of applications and issued Marketing Denial Orders (“MDOs”) for more than 992,000 flavored ENDS products, while issuing zero marketing authorizations. Unfortunately, despite submitting a comprehensive PMTA and continuing to develop robust and reliable product-specific scientific evidence demonstrating the public health benefit of its flavored ENDS products, Bidi, along with nearly every other company in the ENDS industry, received a MDO for its non-tobacco flavored BIDI® Sticks, including its Arctic (menthol) BIDI® Stick, which the FDA mischaracterized as “flavored”. However, because its Arctic BIDI® Stick is menthol, Bidi believes its menthol BIDI® Stick is not subject to the MDO. This position is aligned with the FDA’s public statements and press releases stating that tobacco and menthol ENDS are not deemed flavored products subject to the MDOs. Accordingly, along with the Classic (tobacco) BIDI® Stick, Bidi intends to continue to manufacture and market its Arctic (menthol) BIDI® Stick for distribution by us.
Historically, substantially all of our revenues were derived from sales of flavored BIDI® Sticks, including the Arctic (menthol) BIDI® Stick, sales of which constituted approximately 15.2% and 18.5%, respectively, of our total sales of BIDI® Sticks for the three and nine months ended July 31, 2021. Generally, substantially all of the ENDS industry revenue is derived from the sales of flavored products.
Following the issuance of the MDOs, nearly all manufacturers, not only BIDI, will be limited to manufacturing and selling only tobacco and menthol ENDS products. Accordingly, we believe that consumers are likely to modify their purchases to shift to products that are available and, thus, that a substantial amount of our revenue that had previously been generated from sales of flavored BIDI® Sticks (other than Arctic) may be replaced through sales of the Classic (tobacco) and Arctic (menthol) BIDI® Sticks, given that consumers will only be able to purchase, on a legal basis, non-flavored ENDS products. Accordingly, we believe revenues for tobacco and menthol ENDS products will restore some or all of the revenue we derived from the sale of flavored products. Moreover, based on sales and consumer data, we believe that our consumers are loyal to the Bidi brand and BIDI® Sticks and that they thus are likely to continue to purchase our Classic (tobacco) and Arctic (menthol) BIDI® Sticks in lieu of the flavored BIDI® Sticks they may have bought in the past.
Recent KAVL News
- Kaival Brands Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 10:15:33 PM
- Kaival Brands Provides Business Update in Letter to Shareholders • GlobeNewswire Inc. • 02/14/2024 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:54:48 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/29/2024 10:10:18 PM
- Kaival Brands Partner Bidi Vapor to Contest FDA Denial of ‘Classic’ Tobacco-Flavored ENDS • GlobeNewswire Inc. • 01/29/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:14:06 PM
- Kaival Brands Innovations Group Announces Reverse Stock Split • GlobeNewswire Inc. • 01/23/2024 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 02:00:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/16/2024 05:15:25 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 01/12/2024 10:21:13 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/12/2024 02:59:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:15:44 PM
- Kaival Brands Appoints Executive Chairman Barry Hopkins as Interim Chief Executive Officer and President • GlobeNewswire Inc. • 12/28/2023 01:30:00 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/22/2023 01:00:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/12/2023 09:16:14 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/12/2023 09:05:37 PM
- Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel • GlobeNewswire Inc. • 12/07/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:31:02 PM
- Kaival Brands Expands Senior Management Team with the Appointment of Barry Hopkins as Executive Chairman • GlobeNewswire Inc. • 11/13/2023 01:15:00 PM
- Kaival Brands Leads the Way in Compliance as FDA Ramps Up Enforcement of Illicit Vape Products • GlobeNewswire Inc. • 11/07/2023 01:15:00 PM
- Kaival Brands Innovations Group, Inc. Highlighted in Updated Research Report Released by Harbinger Research, LLC • GlobeNewswire Inc. • 10/12/2023 03:51:16 PM
- Kaival Brands to Present at the Fall Foliage MicroCap Rodeo Conference • GlobeNewswire Inc. • 10/09/2023 08:15:00 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM